{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:26:17Z","timestamp":1783967177147,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>With the advent of new and emerging procedures for benign prostatic hyperplasia (BPH), as well as a greater reliance on medical therapies, trainees may be receiving less exposure to the longstanding gold standard of treatment, transurethral resection of the prostate (TURP). Although TURP outcomes are generally durable, success rates vary. We sought to perform a descriptive analysis of temporal trends in TURP outcomes, evaluating whether those performed prior to 2001 were less likely to require re-operation compared to more contemporary TURP procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We accessed the Veteran\u2019s Affairs (VA) national repository of electronic medical record data. We included veteran males with no prior BPH surgery who received a TURP. We used billing codes to determine retreatment and complications rates within 5 years of TURP. Outcomes were assessed via logistic regression analysis to compare TURP outcomes from before and after the year 2001. Comparisons between variables were done via Chi-Square test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      2,084 underwent TURP prior to 2001 and 35,817 underwent TURP after 2001. Patients undergoing TURP after 2001 were more likely to undergo new procedures within 5 years (15.4% vs. 10.3%, OR 1.49, 95% CI 1.29\u20131.73,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and be on BPH medications postoperatively (65% vs. 30%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). However, these post-2001 patients were also less likely to have incontinence (15.5% vs. 19.7%, OR 0.60, 95% CI 0.53\u20130.67,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TURP prior to 2001 was associated with lower reoperation rate or continue medical therapy, however it was associated with higher rates of incontinence. Several potential explanations exist for these trends, and future studies are necessary to elucidate the reasons for them.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00345-025-06083-5","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T12:09:51Z","timestamp":1763381391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The 21st century marks a rise in TURP retreatment rates: an analysis of Veterans Health Administration data"],"prefix":"10.1007","volume":"43","author":[{"given":"Sirpi","family":"Nackeeran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie M.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer T.","family":"Anger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Sur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4440-1477","authenticated-orcid":false,"given":"Tyler","family":"Sheetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"6083_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ucl.2016.04.001","volume":"43","author":"KB Egan","year":"2016","unstructured":"Egan KB (2016) The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am 43:289\u2013297","journal-title":"Urol Clin North Am"},{"key":"6083_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.31","volume":"2","author":"B Chughtai","year":"2016","unstructured":"Chughtai B, Forde JC, Thomas DDM et al (2016) Benign prostatic hyperplasia. Nat Rev Dis Primers 2:16031","journal-title":"Nat Rev Dis Primers"},{"key":"6083_CR3","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/S0022-5347(01)62196-7","volume":"160","author":"AM De Marzo","year":"1998","unstructured":"De Marzo AM, Nelson WG, Meeker AK, Coffey DS (1998) Stem cell features of benign and malignant prostate epithelial cells. J Urol 160:2381\u20132392","journal-title":"J Urol"},{"key":"6083_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0090-4295(01)01300-0","volume":"58","author":"MJ Barry","year":"2001","unstructured":"Barry MJ (2001) Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia. Urology 58:25\u201332","journal-title":"Urology"},{"key":"6083_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0090-4295(98)00475-0","volume":"53","author":"NR Netto","year":"1999","unstructured":"Netto NR, de Lima ML, Netto MR, D\u2019Ancona CA (1999) Evaluation of patients with bladder outlet obstruction and mild international prostate symptom score followed up by watchful waiting. Urology 53:314\u2013316","journal-title":"Urology"},{"key":"6083_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P et al (2024) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol 211:11\u201319","journal-title":"J Urol"},{"key":"6083_CR7","first-page":"462","volume":"10","author":"TM Nicholson","year":"2022","unstructured":"Nicholson TM, Best SL, Ricke EA, Timms BG, Ricke WA (2022) White\u2019s operation: the history of 19th century attempts to treat prostate disease with castration. Am J Clin Exp Urol 10:462\u2013466","journal-title":"Am J Clin Exp Urol"},{"key":"6083_CR8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1308\/rcsann.2018.0054","volume":"100","author":"MJ Young","year":"2018","unstructured":"Young MJ, Elmussareh M, Morrison T, Wilson JR (2018) The changing practice of transurethral resection of the prostate. Ann R Coll Surg Engl 100:326\u2013329","journal-title":"Ann R Coll Surg Engl"},{"key":"6083_CR9","first-page":"1","volume":"8","author":"JD McConnell","year":"1994","unstructured":"McConnell JD, Barry MJ, Bruskewitz RC (1994) Benign prostatic hyperplasia: diagnosis and treatment. Agency for health care policy and research. Clin Pract Guidel Quick Ref Guide Clin 8:1\u201317","journal-title":"Agency for health care policy and research. Clin Pract Guidel Quick Ref Guide Clin"},{"key":"6083_CR10","first-page":"252","volume":"14","author":"JR LaBossiere","year":"2020","unstructured":"LaBossiere JR, Wallis CJD, Herschorn S, Carr L, Saskin R, Nam R (2020) Surgical management of benign prostatic obstruction: 20-year population-level trends. Can Urol Assoc J 14:252\u2013257","journal-title":"Can Urol Assoc J"},{"key":"6083_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1464-410X.2010.09737.x","volume":"108","author":"J Izard","year":"2011","unstructured":"Izard J, Nickel JC (2011) Impact of medical therapy on transurethral resection of the prostate: two decades of change. BJU Int 108:89\u201393","journal-title":"BJU Int"},{"key":"6083_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4103\/aja.aja_68_20","volume":"23","author":"ZF Peng","year":"2021","unstructured":"Peng ZF, Zhou J, Song P et al (2021) Retrospective analysis of the changes in the surgical treatment of benign prostatic hyperplasia during an 11-year period: a single-center experience. Asian J Androl 23:294\u2013299","journal-title":"Asian J Androl"},{"key":"6083_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/JU.0000000000000319","volume":"202","author":"HE Foster","year":"2019","unstructured":"Foster HE, Dahm P, Kohler TS et al (2019) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2019. J Urol 202:592\u2013598","journal-title":"J Urol"},{"key":"6083_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/bco2.121","volume":"3","author":"KC Zorn","year":"2022","unstructured":"Zorn KC, Bidair M, Trainer A et al (2022) Aquablation therapy in large prostates (80\u2013150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results. BJUI Compass 3:130\u2013138","journal-title":"BJUI Compass"},{"key":"6083_CR15","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.juro.2013.05.116","volume":"190","author":"CG Roehrborn","year":"2013","unstructured":"Roehrborn CG, Gange SN, Shore ND et al (2013) The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. study. J Urol 190:2161\u20132167","journal-title":"J Urol"},{"key":"6083_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.urology.2018.12.041","volume":"126","author":"KT McVary","year":"2019","unstructured":"McVary KT, Rogers T, Roehrborn CG (2019) Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology 126:171\u2013179","journal-title":"Urology"},{"key":"6083_CR17","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/01.ju.0000139541.68542.f6","volume":"172","author":"AE Te","year":"2004","unstructured":"Te AE, Malloy TR, Stein BS et al (2004) Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first united States multicenter prospective trial. J Urol 172:1404\u20131408","journal-title":"J Urol"},{"key":"6083_CR18","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/j.juro.2008.08.019","volume":"180","author":"MR Humphreys","year":"2008","unstructured":"Humphreys MR, Miller NL, Handa SE, Terry C, Munch LC, Lingeman JE (2008) Holmium laser enucleation of the prostate\u2014outcomes independent of prostate size? J Urol 180:2431\u20132435","journal-title":"J Urol"},{"key":"6083_CR19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.jvir.2016.04.001","volume":"27","author":"JM Pisco","year":"2016","unstructured":"Pisco JM, Bilhim T, Pinheiro LC et al (2016) Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol 27:1115\u20131122","journal-title":"J Vasc Interv Radiol"},{"key":"6083_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1590\/S1807-59322008000300005","volume":"63","author":"J Cury","year":"2008","unstructured":"Cury J, Coelho RF, Bruschini H, Srougi M (2008) Is the ability to perform transurethral resection of the prostate influenced by the surgeon\u2019s previous experience? Clin (Sao Paulo) 63:315\u2013320","journal-title":"Clin (Sao Paulo)"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06083-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-06083-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06083-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:02:31Z","timestamp":1767999751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-06083-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6083"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-06083-5","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study is a retrospective review using existing data completed under the Veterans Affairs Institutional Review Board Approval #H150169. Therefore individual consents were not obtained but all research was performed in accordance with guidelines regarding analyses of retrospective data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"701"}}